Osteoporosis Drug Shows Promise for Back Pain Relief

For the first time, researchers have found a way to block spinal disc damage using a drug already proven safe in patients.

Scientists at the Universities of Edinburgh and Bristol were studying zebrafish with a faulty collagen gene when they noticed something remarkable. As the fish aged, their spines developed the same kind of deterioration that causes chronic back pain in people.

The team watched as minerals built up between the fish's vertebrae, hardening tissue that should stay flexible. But this mineralization didn't happen right away. First, a supportive layer in the developing spine began breaking down, and only then did the damaging mineral deposits appear.

When researchers examined which genes had become more or less active, they found problems with fat processing and phosphate control. Both processes are known to cause abnormal mineral buildup in the body.

Then came the exciting part. The scientists tested a bisphosphonate, a medication already used to treat osteoporosis, on the affected fish. The drug prevented minerals from accumulating in their spines.

Reducing the fish's food intake and using drugs that suppress fat metabolism also reduced spinal fusion. These findings point to multiple pathways researchers could target to develop new treatments.

Why This Inspires

Back pain affects 9.5 million people in the UK alone, yet surgery remains the only long-term solution. No medication currently exists that can halt or reverse disc degeneration. Many patients live for decades managing pain without real treatment options.

Dr. Erika Kague, who led the study, put it simply: "For decades, surgery has been the only real answer for disc disease." Now her team has identified several ways to slow down the hardening process, including a drug already used safely in patients.

The research, funded by Arthritis UK and published in Communications Biology, highlights phosphate regulation and fat metabolism as especially promising areas for future medicines. Because bisphosphonates are already approved for human use, testing them for back pain could happen faster than developing entirely new drugs.

For a condition that has affected generations without treatment in sight, this zebrafish discovery opens doors that seemed closed.